 |
|
Gene, stem cell therapy only needs to be 50 percent effective to create a healthy heart
November 01, 2007Findings have major implications for those suffering from muscular dystrophy and heart disease
COLUMBIA, Mo. - Heart disease is the leading cause of death in the United States and greatly affects the quality and length of life for individuals with specific forms of muscular dystrophy. Recent discoveries have demonstrated that gene and/or stem cell therapy could help a variety of organs in the body, but until now scientists have been unsure whether the heart could benefit from these treatments. According to a new study, recently published in Circulation Research, a journal of the American Heart Association, University of Missouri-Columbia researchers have demonstrated that a muscular dystrophy patient should be able to maintain a normal lifestyle if only 50 percent of the cells of the heart are healthy.
Patients with Duchenne muscular dystrophy and Becker muscular dystrophy have a gene mutation that disrupts the production of a protein known as dystrophin. Absence of this protein starts a chain reaction that eventually leads to muscle cell degeneration and death. Eventually, the damaged muscle tissue is replaced by fibrous, bony or fatty tissue and loses function. In the heart, this leads to severe heart disease and can place severe limitations on individuals afflicted with the disease.
In the past, scientists believed that the only way to have a healthy heart was to rid the heart of all damaged tissue. The heart is considered to be a "synchronized organ;" therefore, it was believed that the heart needed to maintain 100 percent normal cells in order to stay healthy.
In gene therapy, mutated genes are replaced with healthy genes. In stem cell therapy, diseased cells are replaced with healthy cells. However, in these gene and stem cell therapies, it is not feasible to fix every cell in the heart. Previously, scientists were uncertain whether partial correction could benefit patients.
"In our study, we found that a heart with 50 percent normal cells looks like a normal heart," said Dongsheng Duan, an associate professor of molecular microbiology and immunology at the MU School of Medicine. "More importantly, it acts like a normal heart. This is the first time that we have concrete evidence that partial gene or cell therapies will be effective for preventing heart disease in a mouse model of muscular dystrophy."
"It's important to note that this could improve the quality of life for individuals who have this heart condition," said Brian Bostick, a doctoral student in molecular microbiology and immunology and the first author of the study. "We're also looking at this as a possible way to prevent heart disease. If we can treat it early through gene therapy or cell therapy, we know now that it can be very beneficial for patients."
The MU researchers said that this finding would have a positive impact on the ongoing gene and cell therapy studies in animal models of muscular dystrophy as well as in human patients. It also raises the hope of developing effective gene and cell therapies for patients suffering from other heart diseases.
University of Missouri-Columbia
In the past, scientists believed that the only way to have a healthy heart was to rid the heart of all damaged tissue. The heart is considered to be a "synchronized organ;" therefore, it was believed that the heart needed to maintain 100 percent normal cells in order to stay healthy.
In gene therapy, mutated genes are replaced with healthy genes. In stem cell therapy, diseased cells are replaced with healthy cells. However, in these gene and stem cell therapies, it is not feasible to fix every cell in the heart. Previously, scientists were uncertain whether partial correction could benefit patients.
"In our study, we found that a heart with 50 percent normal cells looks like a normal heart," said Dongsheng Duan, an associate professor of molecular microbiology and immunology at the MU School of Medicine. "More importantly, it acts like a normal heart. This is the first time that we have concrete evidence that partial gene or cell therapies will be effective for preventing heart disease in a mouse model of muscular dystrophy."
"It's important to note that this could improve the quality of life for individuals who have this heart condition," said Brian Bostick, a doctoral student in molecular microbiology and immunology and the first author of the study. "We're also looking at this as a possible way to prevent heart disease. If we can treat it early through gene therapy or cell therapy, we know now that it can be very beneficial for patients."
The MU researchers said that this finding would have a positive impact on the ongoing gene and cell therapy studies in animal models of muscular dystrophy as well as in human patients. It also raises the hope of developing effective gene and cell therapies for patients suffering from other heart diseases.
University of Missouri-Columbia
Muscular Dystrophy News and Current Muscular Dystrophy Events RSSPTC124 shows activity in cystic fibrosis; Phase 2 proof-of-concept data published in Lancet
New phase 2 data published today in The Lancet show that the investigational oral drug PTC124 demonstrates activity in nonsense-mutation cystic fibrosis (CF). The data show that treatment with PTC124 results in statistically significant improvements in the chloride channel function of patients with nonsense-mutation CF. The study was conducted at the Hadassah Hebrew University Hospital in Jerusalem, Israel and sponsored by PTC Therapeutics (PTC).
RNA emerges from DNA's shadow
RNA, the transporter of genetic information within the cell, has emerged from the shadow of DNA to become one of the hottest research areas of molecular biology, with implications for many diseases as well as understanding of evolution.
Stanford researchers take first look at working muscle fiber
Using an unusual microscope with a tip the size of a needle, Stanford researchers are now able to look at tiny fibers of working muscles in live humans, with minimum discomfort to the patient-a development patients are sure to welcome.
Embryo biopsy does not affect early growth and risk of congenital malformations in PGD/PGS babies
A study of 70 singleton babies born after preimplantation genetic diagnosis and screening has shown that the procedure does not adversely affect their early growth and risk of congenital malformations.
New approach to protect the hearts of patients with muscular dystrophy
A team of researchers has recently shown that the administration of sildenafil protects the heart in mice with Duchenne muscular dystrophy.
Researchers discover molecular basis of a form of muscular dystrophy
A team of French and German researchers report in the May 2008 print issue of The FASEB Journal (http://www.fasebj.org) that people with limb-girdle muscular dystrophy are missing a protein called c-FLIP, which the body uses to prevent the loss of muscle tissue.
Penn Researchers Identify First Sex Chromosome Gene Involved in Meiosis and Male Infertility
A team of scientists led by University of Pennsylvania veterinary researchers have identified a gene, TEX11, located on the X chromosome, which when disrupted in mice renders the males sterile and reduces female fecundity. This is the first study of the genetic causes of infertility that links a particular sex chromosome meiosis-specific gene to sterility.
Investigational drug tested for preventing muscle fiber death in muscular dystrophy
An investigational antiviral drug currently undergoing human trials in Europe for treating Hepatitis C infections may have potential to reduce muscle cell damage in Duchenne and other forms of muscular dystrophy (MD).
Long-term muscle improvements shown in gene therapy study in mice
Injecting a gene responsible for making a specific protein into a mouse that's used as a model for muscular dystrophy can lead to long-term improvements in the animal's muscle size and strength, a new study shows.
Research shows promise for potential new gene therapy strategy for muscle-wasting diseases
Investigators in The Research Institute at Nationwide Children's Hospital have identified the role of a protein that could potentially lead to new clinical treatments to combat musculoskeletal diseases, including Duchenne muscular dystrophy (DMD).
More Muscular Dystrophy News Articles
 | Reflections of a Peacemaker: A Portrait Through Heartsongs by Mattie J.T. Stepanek Mattie J. T. Stepanek lived and died a child, but he had the spirit of a giant. Affected by a rare and fatal neuromuscular disease, Mattie lived almost fourteen years but in that time became a poet, best-selling author, peace activist, and a prominent voice for the Muscular Dystrophy Association. Before his death in June 2004, his five volumes of Heartsongs poetry sold more than a million copies.... |
 | Journey Through Heartsongs by Mattie J. T. Stepanek Mattie J.T. Stepanek takes us on a Journey Through Heartsongs with more of his moving poems. These poems share the rare wisdom that Mattie has acquired through his struggle with a rare form of muscular dystrophy and the death of his three siblings from the same disease. His life view is one of love and generosity and as a poet and a peacemaker, his desire is to bring his message of peace to as... |
 | Heartsongs by Mattie J. T. Stepanek Now available in hardcover, a special gift edition with 16 pages of new poems and illustrations, the national bestseller that introduced millions of people to Mattie J.T.... |
 | My Buddy (An Owlet Book) by Audrey Osofsky Buddy is the best dog a boy could have. He and his master are always together. They play ball, and go for walks, and take good care of each other. Nothing can separate them. They're a... |
 | Hope Through Heartsongs by Mattie J. T. Stepanek The celebrated child Mattie J.T. Stepanek continues his internationally inspiring poetry with Hope Through Heartsongs. For those who haven't followed Stepanek's rise to fame, this young phenomenon writes poetry that is wise beyond his years and has appeared on The Oprah Winfrey Show and Larry King Live. Indeed, as Gary Zukav marvels in the book's foreword, Stepanek's wisdom seems to extend beyond... |
 | Celebrate Through Heartsongs by Mattie J. T. Stepanek attie J.T. Stepanek is an award-winning poet whose struggle with a rare form of muscular dystrophy has touched the lives of people nationwide. Celebrate Through Heartsongs, his fourth inspiring collection of poetry, features works written between the ages of three and eleven, and continues to spread Mattie's message of universal hope, peace, courage, and love. Fully illustrated by the poet, the... |
 | Muscular Dystrophy in Children: A Guide for Families by Irwin M. Siegel This book was written for parents, families, teachers, and friends of children with muscular dystrophy (MD), and for older children. It guides the child and caregivers through the often frightening labyrinth of medical care that one enters when diagnosed with MD. The book will help the reader understand the significance of the signs and symptoms of the disease, the treatment options available,... |
 | Loving Through Heartsongs by Mattie J. T. Stepanek attie J.T. Stepanek has won the hearts of millions with his inspiring poems from his first two New York Times bestsellers. Now he's ready to spread a little love with Loving Through Heartsongs, a beautiful collection of poems written about innocence and trusting love from a child's perspective. Mattie's struggle with muscular dystrophy has never kept him from feeling deep love for his family,... |
 | Adrenaline by John B. Olson Set in the not-so-distant future, Adrenaline introduces James Parker, a biochemistry grad student who discovers a cure for muscular dystrophy, the disease confining him to a wheelchair. However, the cure that began as his salvation appears to have bizarre side effects that open the door to an existence he never imagined. Darcy Williams, an attractive, intelligent, and delightfully quirky fellow... |
 | You've Gotta Fight Back!: Winning with Serious Illness, Injury or Disability by Dirk, Chase Eldredge The heart of this book consists of thirteen, riveting, in-depth stories of people who fought back with courage, humor, and a positive attitude. In doing so, they have provided valuable guidance for you, the readers of this inspiring work. The seriously ill, their friends and family will gain priceless advice on coping, dealing with depression, how to partner with the medical profession, the... |
| © 2008 BrightSurf.com |